Journal
CRYSTAL GROWTH & DESIGN
Volume 12, Issue 4, Pages 2122-2126Publisher
AMER CHEMICAL SOC
DOI: 10.1021/cg300152p
Keywords
-
Funding
- National Institutes of Health [GM072737]
Ask authors/readers for more resources
Crystal structures for the commercial monohydrate form and an anhydrate form of dasatinib, an oral anticancer agent, are presented along with characterization by Raman spectroscopy, powder X-ray diffraction, differential scanning calorimetry, and thermogravimetric analysis. Solubility measurements conducted in water reveal that the anhydrate has dramatically improved solubility compared to the commercial hydrate form. Finally, dasatinib is a rare example of a promiscuous solvate former, and the basis for this behavior can now be understood by examining the poor packing efficiency in the unsolvated form.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available